Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
235 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (2)
  • Currently Recruiting (1)
  • (-) Closed (1)

Medical Condition

  • Show all (75)
  • Autoimmune Disorders (1)
  • Blood Disorders (3)
  • Bone & Muscle (1)
  • Cancer (17)
    • Breast Cancer (1)
    • Gynecologic Cancer (2)
    • Head and Neck Cancer (1)
    • (-) Leukemia (1)
    • Lung Cancer (2)
    • Multiple Myeloma (2)
    • Pancreatic Cancer (1)
    • Solid Tumors (2)
    • Uveal Melanoma (2)
  • COVID-19 (Coronavirus) (4)
  • Endocrine & Metabolic Disease (2)
  • Healthy Volunteers (10)
  • Heart Disease (14)
  • Kidney Disease (1)
  • Liver Disease (1)
  • Lung Disease (2)
  • Neurological Disorders (3)
  • Nutrition (1)
  • Obstetrics & Gynecology (3)
  • Pediatrics (7)
  • Surgery (2)
  • Transplant (3)
Displaying 1 - 1 of 1

A study for patients acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm using study drug SL-401

Condition: Cancer / Leukemia
Investigator: Todd Rosenblat, MD
Status: Closed
The goal of this research study is to find the safest highest dose of SL-401 that can be given to patients with AML or BPDCN. This study will also look at how SL-401 stops or slows leukemia or BPDCN growth and how SL-401 enters and leaves the body. This study will also look at certain proteins in the …
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science